|
Market Closed -
Euronext Paris
12:55:00 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 79.74 EUR | +4.71% |
|
+7.58% | -3.60% |
| Oct. 30 | Sanofi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Oct. 30 | Sanofi Revised Earning Guidance for the Fiscal Year 2026 | CI |
| Market Cap | 95.53B 107B 87.88B 79.62B 149B 10,128B 152B 1,048B 421B 5,328B 400B 392B 16,802B | P/E 2026 * |
12.7x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 107B 119B 98.14B 88.92B 166B 11,311B 169B 1,170B 470B 5,950B 447B 438B 18,764B | EV / Sales 2026 * |
2.24x | EV / Sales 2027 * | 2.04x |
| Free-Float |
88.34% | Yield 2026 * |
5.35% | Yield 2027 * | 5.66% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
London S.E.
| 0O59 | Delayed | |
Tradegate
| SNW | Real-time | |
Xetra
| SNW | Delayed | |
Börse Stuttgart
| SNW | Delayed | |
Boerse Muenchen
| SNW | Real-time | |
Borsa Italiana
| 1SAN | End-of-day quote | |
Deutsche Boerse AG
| SNW | Delayed | |
Wiener Boerse
| SANO | End-of-day quote | |
CBOE
| 0O59 | Real-time | |
OTC Markets
| SNYNF | Delayed | |
Bulgaria S.E.
| SNW | End-of-day quote | |
Swiss Exchange
| SAN | Delayed |
Last Transcript: Sanofi
| Oct. 30 | Sanofi: Impressive Q3 beat; depressed valuation limits downside risks | ![]() |
| Oct. 30 | Sanofi : Jefferies keeps its Buy rating | ZD |
| Oct. 30 | Sanofi : Bernstein keeps its Buy rating | ZD |
| Oct. 30 | Sanofi : JP Morgan is Neutral | ZD |
| Oct. 26 | A Week of Reckoning for Wall Street |
| 1 day | +4.71% | ||
| 1 week | +7.58% | ||
| Current month | +9.77% | ||
| 1 month | +9.77% | ||
| 3 months | +9.58% | ||
| 6 months | -0.10% | ||
| Current year | -3.60% |
| 1 week | 74.25 | 81.19 | |
| 1 month | 69.75 | 81.19 | |
| Current year | 69.75 | 84.97 | |
| 1 year | 69.75 | 90.79 | |
| 3 years | 69.75 | 110.88 | |
| 5 years | 69.75 | 110.88 | |
| 10 years | 62.88 | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 8/20/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.71% | +7.58% | -9.46% | -5.23% | 107B | ||
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | ||
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | ||
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | ||
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | ||
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | ||
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | ||
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | ||
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | ||
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | ||
| Average | +2.03% | +6.07% | +40.98% | +74.30% | 436.86B | |
| Weighted average by Cap. | +1.28% | +6.62% | +49.41% | +95.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.6B 53.15B 43.78B 39.67B 74.16B 5,046B 75.54B 522B 210B 2,655B 199B 195B 8,372B | 50.7B 56.61B 46.64B 42.26B 78.99B 5,376B 80.47B 556B 223B 2,828B 212B 208B 8,918B |
| Net income | 7.69B 8.59B 7.07B 6.41B 11.98B 815B 12.21B 84.36B 33.86B 429B 32.23B 31.54B 1,353B | 9.1B 10.16B 8.37B 7.58B 14.17B 965B 14.44B 99.8B 40.06B 507B 38.13B 37.32B 1,600B |
| Net Debt | 11.15B 12.45B 10.26B 9.3B 17.38B 1,182B 17.7B 122B 49.11B 622B 46.74B 45.74B 1,962B | 7.68B 8.58B 7.07B 6.4B 11.97B 814B 12.19B 84.27B 33.83B 428B 32.19B 31.51B 1,351B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | €79.74 | +4.71% | 8,149,616 |
| 26-10-29 | €76.15 | +0.85% | 3,096,724 |
| 26-10-28 | €75.51 | +0.48% | 2,827,293 |
| 26-10-27 | €75.15 | +0.76% | 1,783,437 |
| 26-10-26 | €74.58 | +0.62% | 1,802,573 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions



















